08-07-2009

The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace with the evolving demands of the medical fraternity. New analysis from Frost & Sullivan, European Medical Device Company ...

more

08-07-2009

Millipore Corporation and Proteome Sciences plc announced they have signed an exclusive license agreement to develop new products that will help to advance the study of Alzheimer’s disease. Under the terms of the agreement, Millipore will develop Luminex bead-based multiplex immunoassays to ...

more

07-07-2009

XENTION LTD announced that it had received a substantial award from the Wellcome Trust to support pioneering work on an exciting target for atrial fibrillation. The award, made under Wellcome’s Seeding Drug Discovery initiative, will provide up to £3 million to fund Xention’s IKACh programme ...

more

07-07-2009

PolyTherics Limited announced that a second patent has been allowed covering the targeted PEGylation of proteins. Issued by the United States Patent Office, this allowance protects PolyTherics’ PEGylation technology in the two largest pharmaceutical markets in the world. This news comes two ...

more

06-07-2009

Scientists are to study a group of proteins that are highly effective at killing bacteria and which could hold the key to developing new types of antibiotics. Researchers from the Universities of York and Leeds have been awarded £3.3m from the Biotechnology and Biological Sciences Research ...

more

03-07-2009

Successful business applications such as drug screening technologies, flat-panel displays and solar-cell designs are amongst the achievements in physics recognised by the Institute of Physics' (IOP) 2009 awards along with leading research in a wide range of fields from astronomy to optical ...

more

03-07-2009

Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab), is the winner of the 2009 Dr. Paul Janssen ...

more

Research may ultimately track the uptake of drugs by the body's cells

02-07-2009

Researchers in the Department of Physics and Astronomy at the University of Leicester have developed a new synthesis method, which has led them to the discovery of fluorescent silicon nanoparticles and may ultimately help track the uptake of drugs by the body's cells. Dr Klaus von Haeften ...

more

01-07-2009

RTS Life Science has partnered with Hall Analytical Laboratories to provide analytical services and consultancy in the area of automation and inhaler testing. Initially focussed on inhaled drug delivery devices, the two companies will share facilities, technology and resources to provide a ...

more

30-06-2009

Vantia Therapeutics announced positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia. The trial showed that oral VA106483 was successful in producing a predictable and sustained anti-diuretic effect in patients, as determined by increased ...

more